Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Cytochroma, a clinical stage specialty pharmaceutical company, has appointed Steven Engel as its new vice president of regulatory affairs and quality assurance.
Subscribe to our email newsletter
Dr Engel brings to Cytochroma over 20 years of experience in regulatory affairs and quality assurance, and will be responsible for directing all of Cytochroma’s regulatory activities, as well as ensuring that the company has appropriate quality systems in place.
Prior to joining Cytochroma, Dr Engel was vice president of regulatory affairs and clinical quality compliance at Par Pharmaceutical, where he was responsible for the regulatory strategies of both branded and generic pharmaceutical programs.
Charles Bishop, president and CEO of Cytochroma, said: “Steve has a proven track record of successful new drug registrations and post-marketing support, and we are pleased to have an individual of this caliber helping us secure global regulatory approvals for our products.”